1. Home
  2. HIW vs IDYA Comparison

HIW vs IDYA Comparison

Compare HIW & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HIW

Highwoods Properties Inc.

HOLD

Current Price

$27.98

Market Cap

2.8B

Sector

Real Estate

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$28.43

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIW
IDYA
Founded
1978
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.6B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
HIW
IDYA
Price
$27.98
$28.43
Analyst Decision
Hold
Strong Buy
Analyst Count
7
16
Target Price
$27.57
$52.86
AVG Volume (30 Days)
1.3M
689.0K
Earning Date
04-28-2026
05-06-2026
Dividend Yield
8.43%
N/A
EPS Growth
54.26
61.90
EPS
0.29
N/A
Revenue
$806,112,000.00
$218,710,000.00
Revenue This Year
$6.03
N/A
Revenue Next Year
$3.58
$201.05
P/E Ratio
$95.17
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$20.45
$20.50
52 Week High
$32.76
$39.28

Technical Indicators

Market Signals
Indicator
HIW
IDYA
Relative Strength Index (RSI) 76.23 44.26
Support Level $25.13 $27.66
Resistance Level $27.98 $29.74
Average True Range (ATR) 0.66 1.02
MACD 0.11 0.06
Stochastic Oscillator 97.98 32.46

Price Performance

Historical Comparison
HIW
IDYA

About HIW Highwoods Properties Inc.

Highwoods Properties Inc is a fully integrated office REIT that owns, develops, acquires, leases, and manages office properties mainly in the best business districts of Atlanta, Charlotte, Dallas, Nashville, Orlando, Raleigh, Richmond, and Tampa. Its principal business is the operation, acquisition, and development of rental office properties, with no material inter-segment transactions. The Company evaluates performance by geographic location, and the operating results by geographic grouping are regularly reviewed by the chief operating decision maker. The core portfolio consists mainly of office properties in its key markets, with the majority of revenue derived from its Raleigh properties.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: